Organicell Reports the Expansion of its Trial for Zofin to Treat COVID-19 Patients in India

 Organicell Reports the Expansion of its Trial for Zofin to Treat COVID-19 Patients in India

Organicell Reports the Expansion of its Trial for Zofin to Treat COVID-19 Patients in India

Shots:

  • The company reported the positive results of the initial trial for Zofin in the first 10 COVID-19 patients treated with Zofin in India. The trial is being conducted with CWI India and showed all patients have recovered from their symptoms and were discharged from the hospital
  • Based on the positive results, the trial will be expanded to additional 65 patients with the mod. to sev. COVID-19 and is expected to be completed by Jun’2021
  • If the expanded trial will show similar results as an initial trial, Organicell and CWI India plan to file EUA with the ICMR to use Zofin in India as a treatment for COVID-19

Click here to­ read full press release/ article | Ref: Business Wire | Image: Business Wire

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post